Characterization of the impact to PET quantification and image quality of an anterior array surface coil for PET/MR imaging

MAGMA. 2014 Apr;27(2):149-59. doi: 10.1007/s10334-013-0388-1. Epub 2013 Jun 26.

Abstract

Object: The aim of this study was to determine the impact to PET quantification, image quality and possible diagnostic impact of an anterior surface array used in a combined PET/MR imaging system.

Materials and methods: An extended oval phantom and 15 whole-body FDG PET/CT subjects were re-imaged for one bed position following placement of an anterior array coil at a clinically realistic position. The CT scan, used for PET attenuation correction, did not include the coil. Comparison, including liver SUV(mean), was performed between the coil present and absent images using two methods of PET reconstruction. Due to the time delay between PET scans, a model was used to account for average physiologic time change of SUV.

Results: On phantom data, neglecting the coil caused a mean bias of -8.2% for non-TOF/PSF reconstruction, and -7.3% with TOF/PSF. On clinical data, the liver SUV neglecting the coil presence fell by -6.1% (± 6.5%) for non-TOF/PSF reconstruction; respectively -5.2% (± 5.3%) with TOF/PSF. All FDG-avid features seen with TOF/PSF were also seen with non-TOF/PSF reconstruction.

Conclusion: Neglecting coil attenuation for this anterior array coil results in a small but significant reduction in liver SUV(mean) but was not found to change the clinical interpretation of the PET images.

Publication types

  • Review

MeSH terms

  • Equipment Design
  • Equipment Failure Analysis
  • Fluorodeoxyglucose F18
  • Humans
  • Image Enhancement / instrumentation*
  • Image Enhancement / methods*
  • Liver Diseases / diagnosis*
  • Magnetic Resonance Imaging / instrumentation*
  • Magnetic Resonance Imaging / methods
  • Magnetics / instrumentation
  • Multimodal Imaging / instrumentation*
  • Multimodal Imaging / methods
  • Phantoms, Imaging
  • Positron-Emission Tomography / instrumentation*
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Transducers
  • Whole Body Imaging / instrumentation*
  • Whole Body Imaging / methods

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18